Plasma urate concentrations and possible REM sleep behavior disorder.

Yun Shen, Junjuan Li, Michael Schwarzschild, Milena Pavlova, Songbin He, Alberto Ascherio, Shouling Wu, Liufu Cui, Xiang Gao

Journal: Annals of clinical and translational neurology 2020;6(12):2368-2376

PMID: 31714690

Abstract

OBJECTIVE

To examine how urate concentrations are related to the risk of having possible REM sleep behavior disorder (pRBD) in a community-based cohort.

METHODS

The study included 12,923 Chinese adults of the Kailuan Study, free of Parkinson disease (PD) and dementia. Plasma urate concentrations were measured in 2006, 2008, and 2010. Cumulative average urate concentration was used as primary exposure. In 2012, we determined pRBD status using a validated RBD questionnaire-Hong Kong (RBDQ-HK). Logistic regression analysis was performed to estimate the association between urate concentrations during 2006-2010 and odds of having pRBD in 2012 or pRBD case with symptom onset within 1 year.

RESULTS

Higher average urate concentrations were associated with a lower odds of pRBD (P-trend <0.001). The adjusted odds ratio (OR), for the highest versus lowest urate quintiles, was 0.43 (95% confidence intervals (CIs) 0.32-0.57). Significant association was consistently observed when we examined the association of a single urate assessment (2006 or 2010) or the rate of change in urate concentrations during 2006-2010 with pRBD (P-trend <0.001 for all). However, restricting to pRBD onset during 2011-2012, we observed a nonsignificant trend between high urate concentration and high odds of pRBD (P-trend = 0.09).

INTERPRETATION

Higher average urate concentrations were associated with a lower likelihood of having pRBD, but not new-onset pRBD. Because of its observational study design, the result should be interpreted with caution due to the possibility of residual confounding.

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Address: Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Department of Nephrology, Kailuan General Hospital, Tangshan, China.; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, China.; Department of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts.; Department of Cardiology, Kailuan General Hospital, Tangshan, China.; Department of Rheumatology, Kailuan General Hospital, Tangshan, China.; Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.